ea0029p140 | Bone & Osteoporosis | ICEECE2012
Stepan J.
, Dobnig H.
, Fahrleitner-Pammer A.
, Ma Y.
, Zeng Q.
, Wan X.
, Marin F.
, Pavo I.
Teriparatide (TPTD) reduces the vertebral and nonvertebral fracture risk. TPTD increases bone formation and improves the cancellous bone microstructure which is an important determinant of the mechanical integrity of vertebrae. The aim of our study was to evaluate first time the effect of TPTD on cortical microstructure and dynamic histomorphometric indices in patients with osteoporosis with or without prior therapy with ALN. Sixty-six postmenopausal women with osteoporosis, m...